Home Health & Fitness Oxford To Study Anti-Inflammatory Drug As Covid Treatment

Oxford To Study Anti-Inflammatory Drug As Covid Treatment

Oxford’s trial will be aimed at treating people in the community, especially in care homes. (File)London: Oxford University said on Wednesday it would study whether the world’s best-selling prescription medicine, adalimumab, was an effective treatment for COVID-19 patients – the latest effort to repurpose existing drugs as potential coronavirus therapies.Adalimumab, which is sold under the brand name Humira by AbbVie, is a type of anti-inflammatory known as an anti-tumour necrosis factor (anti-TNF) drug. Recent studies have shown that COVID-19 patients already taking anti-TNF drugs for inflammatory bowel disease and inflammatory arthritis are less likely to be admitted to hospital, Oxford said in a statement.Oxford’s trial, called AVID-CC, will be aimed at treating people in the community, especially in care homes, the university said. It will enrol up to 750 patients from community care settings throughout Britain.Humira is used to treat a range of conditions including rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis.The availability of biosimilar versions of the medicine would make it affordable and accessible if the trial is successful, Oxford said. Novartis makes one of the alternatives, Hyrimoz.Research has identified some treatments for hospitalised COVID-19 patients, including Gilead’s remdesivir as well as the generic steroid drug dexamethasone.Researchers have also studied other anti-inflammatory drugs for treating COVID-19. Severe infections are believed to be triggered by an over-reaction of the immune system, known as a cytokine storm, and drugs that suppress certain elements of the immune system can play a role in arresting a rapid escalation of symptoms.But there are as yet no effective therapies for people who are not admitted to hospital.Care homes were particularly hard hit by the first wave of COVID-19 in the UK and other countries. If Humira were successful against COVID-19, this could help some older people who are some of most vulnerable, it said, at a time when governments are struggling to contain the pandemic.The Oxford study is funded by the COVID-19 Therapeutics Accelerator initiative set up by global health charity Wellcome, as well as the Bill and Melinda Gates Foundation and Mastercard.(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -

Most Popular

How can I tell the difference between the flu and COVID-19?

Last Updated : Oct 01, 2020 01:54 PM IST | Source: AP Body aches, sore throat, fever, cough, shortness of breath, fatigue and headaches are symptoms shared by the two. How can I tell the difference between the flu and COVID-19?It’s impossible to tell without a test. Influenza and COVID-19 have such similar symptoms, you…

Cardiac arrest common in sick Covid-19 patients

Photo for representational purpose only. iStock New York, October 1 Cardiac arrest is common in critically ill patients with Covid-19 and is associated with poor survival, particularly among patients aged 80 or older, say researchers. The findings, published in the journal The BMJ, could help guide end-of-life care discussions with critically ill patients with Covid-19…

Beware: Vitamin D deficiency can make you obese and lead to stunted growth

Vitamin D, or the ‘Sunshine Vitamin as it is also known as, is one of the essential nutrients that makes your bones and teeth stronger, wards off infections and diseases and keeps you cheerful. This fat-soluble vitamin can also bring down your risk of cancer, autoimmune diseases, heart disease and diabetes. But unfortunately, as many…

COVID-19 cases decline, deaths increase in Chandigarh as September ends

Naina MishraTribune News ServiceChandigarh, October 1 As September comes to an end, the Union Territory has started to witness a decline in the number of positive COVID-19 cases, and daily tests.  However, COVID deaths have increased with every passing week.  September has recorded 100 COVID-19 deaths whereas August reported only 39 deaths.  At least three…

Recent Comments